🔎 Trials Near Me

Hjem › Schizofreni › Georgia › Atlanta

Kliniske studier for Schizofreni i Atlanta, GA

22 studier for Schizofreni søker deltakere på steder i og rundt Atlanta (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

RekruttererFase 4
  • Vanda Investigational Site, Atlanta
  • Vanda Investigational Site, Atlanta
  • Vanda Investigational Site, Decatur · 6 mi unna
Alder 12 til 17 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05648591

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

RekruttererFase 1
  • Synexus Clinical Research US Inc, Atlanta
Alder 18 til 55 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

RekruttererFase 3
  • Atlanta Center for Medical Research, Atlanta
Alder 18 til 65 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

RekruttererFase 3
  • CenExeli Research LLC, Atlanta
  • Atlanta Center for Medical Research, Atlanta
Alder 5 til 17 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06229210

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

RekruttererFase 3
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Decatur · 6 mi unna
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

RekruttererFase 3
  • Neurocrine Clinical Site, Atlanta
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07227818

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

RekruttererFase 3
  • Atlanta Center for Medical Research, Atlanta
  • Denali Health Atlanta, LLC, Stone Mountain · 13 mi unna
Alder 5 til 17 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

RekruttererFase 2
  • Atlanta Center for Medical Research, Atlanta
Alder 18 til 55 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07410507

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

RekruttererFase 1
  • CenExel iResearch, LLC, Decatur · 6 mi unna
Alder 18 til 55 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07734493

52-week Open Label Safety-Tolerability Study

RekruttererFase 3
  • CenExel, Atlanta
Alder 18 til 65 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

RekruttererFase 3
  • Atlanta Center for Medical Research, Atlanta
  • Denali Health Atlanta, LLC, Stone Mountain · 13 mi unna
Alder 13 til 17 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

RekruttererFase 1
  • Atlanta Center for Medical Research, Atlanta
  • CenExel iResearch, LLC, Decatur · 6 mi unna
Alder 18 til 55 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

RekruttererFase 2
  • Clinical Site, Atlanta
  • Clinical Site, Decatur · 6 mi unna
Alder 18 til 65 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

RekruttererObservasjonsstudie
  • Emory University., Atlanta
  • Local Institution - 0049, Austell · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

RekruttererFase 3
  • Alkermes Investigator Site, Decatur · 6 mi unna
Alder 10 til 17 · Alle kjønn · Oppdatert 14. aug. 2026 · NCT05303064

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

RekruttererFase 1
  • Bioxcel Clinical Research Site, Decatur · 6 mi unna
Alder 10 til 17 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05025605

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

RekruttererFase 2
  • CenExel iResearch, Decatur · 6 mi unna
Alder 18 til 65 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07467993

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

RekruttererFase 2
  • Cenexel ACMR, Atlanta
  • Cenexel iResearch Atlanta, Decatur · 6 mi unna
Alder 18 til 55 · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07191483

Anti-Inflammatory Challenge in Schizophrenia

RekruttererFase 4
  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital, Atlanta
Alder 18 til 55 · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05823532

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

RekruttererFase 3
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Decatur · 6 mi unna
Alder 18 til 65 · Alle kjønn · Oppdatert 6. mar. 2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

RekruttererFase 3
  • Vanda Investigational Site, Atlanta
Alder 18 til 65 · Alle kjønn · Oppdatert 12. jan. 2026 · NCT06961968

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

RekruttererFase 3Frivillige helsepersonell ønskes velkommen
  • Reviva site, Atlanta
  • Reviva site, Decatur · 6 mi unna
Alder 18 til 65 · Alle kjønn · Oppdatert 19. des. 2024 · NCT05184335

Schizofreni-studier i andre byer

Andre studier i Atlanta

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.